NewslettersNeural Cell NewsTelomerase Inhibition Is an Effective Therapeutic Strategy in TERT Promoter Mutant-Glioblastoma Models with Low Tumor VolumeBy Jamie Kang - January 31, 20230297Researchers used CRISPR interference to knock down TERT expression in TERT promoter-mutant glioblastoma cell lines and patient-derived models. They then measured viability using serial proliferation assays.[Neuro-Oncology]Abstract